These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31218482)

  • 1. Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease.
    Chaudhary R; Sukhi A; Chaudhary R; Jindal M; Vyas A; Rout A; Bliden K; Tantry U; Gurbel P
    J Thromb Thrombolysis; 2019 Oct; 48(3):373-381. PubMed ID: 31218482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of weight gain with coronary artery disease, inflammation and thrombogenicity.
    Chaudhary R; Bliden KP; Tantry US; Mohammed N; Mathew D; Gesheff MG; Franzese CJ; Gurbel PA
    J Thromb Thrombolysis; 2016 Apr; 41(3):394-403. PubMed ID: 26714821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score.
    Bliden KP; Chaudhary R; Navarese EP; Sharma T; Kaza H; Tantry US; Gurbel PA
    Atherosclerosis; 2018 Jan; 268():55-62. PubMed ID: 29175655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy.
    Franzese CJ; Bliden KP; Gesheff MG; Pandya S; Guyer KE; Singla A; Tantry US; Toth PP; Gurbel PA
    Am J Cardiol; 2015 May; 115(9):1204-11. PubMed ID: 25759102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
    Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
    Kreutz RP; Owens J; Breall JA; Lu D; von der Lohe E; Bolad I; Sinha A; Flockhart DA
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):321-6. PubMed ID: 23429252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis.
    Bliden KP; Tantry US; Gesheff MG; Franzese CJ; Pandya S; Toth PP; Mathew DP; Chaudhary R; Gurbel PA
    J Interv Cardiol; 2016 Apr; 29(2):168-78. PubMed ID: 26822493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central aortic pulse pressure, thrombogenicity and cardiovascular risk.
    Chen G; Bliden KP; Chaudhary R; Liu F; Kaza H; Navarese EP; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2017 Aug; 44(2):223-233. PubMed ID: 28695310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
    Sposito AC; Lemos PA; Maranhão RC; Mansur AP; Cesar LA; Ramires JA
    Int J Cardiol; 2003 Oct; 91(2-3):193-200. PubMed ID: 14559130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy and inflammation in patients with diabetes treated with high dose aspirin.
    Chaudhary R; Bliden KP; Garg J; Mohammed N; Tantry U; Mathew D; Toth PP; Franzese C; Gesheff M; Pandya S; Gurbel P
    J Diabetes Complications; 2016; 30(7):1365-70. PubMed ID: 27237049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting.
    Gurbel PA; Bliden KP; Kreutz RP; Dichiara J; Antonino MJ; Tantry US
    Platelets; 2009 Mar; 20(2):97-104. PubMed ID: 19235051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
    Orbe J; Zudaire M; Serrano R; Coma-Canella I; Martínez de Sizarrondo S; Rodríguez JA; Páramo JA
    Thromb Haemost; 2008 Feb; 99(2):382-7. PubMed ID: 18278189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting.
    Gurbel PA; Bliden KP; Cohen E; Navickas IA; Singla A; Antonino MJ; Fissha M; Kreutz RP; Bassi AK; Tantry US
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):268-75. PubMed ID: 18469547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immediate Outcomes of Coronary Artery Bypass Grafting in Patients With Multifocal Atherosclerosis: Gender Differences].
    Sumin AN; Korok EV; Gaifulin RA; Ivanov SV; Barbarash OL
    Kardiologiia; 2016 Aug; 56(8):33-39. PubMed ID: 28290878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain.
    Wu EB; Lumb P; Chambers JB; Crook MA
    Atherosclerosis; 1999 Aug; 145(2):261-6. PubMed ID: 10488951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
    Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH
    Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trends of the Prevalence of Angina With No Obstructive Coronary Artery Disease (ANOCA).
    Patel S; Fung M; Liang Z; Butalia S; Anderson TJ
    Can J Cardiol; 2023 Jan; 39(1):63-70. PubMed ID: 36273723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
    Bordalo AD; Nobre AL; Dantas M; Cravino J
    Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.